|
|
Zhenyu Yang Ph.D.
Associate
Zhenyu Yang focuses on patent litigation, primarily in the areas of biotechnology, pharmaceuticals, and medical devices. Dr. Yang also has experience in patent prosecution, patentability assessments,
freedom-to-operate analyses, invalidity and non-infringement opinions, and due diligence.
Prior to practicing law, Dr. Yang performed research at Novartis Pharmaceuticals Corporation and a biotechnology company. While attending law school, Dr. Yang worked full-time as a patent manager at a global Fortune 100 company.
Dr. Yang frequently teaches in China on topics related to U.S. patent law.
Highlights
- Eli Lilly & Co. v. Actavis Elizabeth, LLC (D.N.J.). Represented Eli Lilly against several generic companies in Abbreviated New Drug Application (ANDA) litigation pertaining to Strattera®, Eli Lilly's prescription medicine for the treatment of attention-deficit/hyperactivity disorder.
- Defended a technology company against trade secret misappropriation assertions.
- Served as a law clerk to the Honorable Paul R. Michel, U.S. Court of Appeals for the Federal Circuit, 2008-2009.
- Worked as an associate in the intellectual property group in the Washington, D.C. office at a top-tier national law firm, 2007-2008.
- Served as a program professor for the School of Public Affairs, University of Science and Technology of China, 2010.
Select Publications
|
|